Toxic proteins linked to Alzheimer’s disease could be reduced by DNA vaccine

In a recently published study in Alzheimer's Research and Therapy, a research team from UT Southwestern’s Medical Center (TX, USA), have demonstrated that a vaccine delivered to the skin stimulates an immune response that reduces build-up of beta-amyloid and tau protein in the brains of mice. "This study is the culmination of a decade of research that has repeatedly demonstrated that this vaccine can effectively and safely target in animal models what we think may cause Alzheimer's disease," explained Roger Rosenberg, UT Southwestern’s Medical Center. "I believe we're getting close to testing this therapy in people." Earlier research found that...